Works matching IS 15228517 AND DT 2022 AND VI 24 AND IP 7

Results: 28
    1

    Forthcoming Meetings.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 7, p. 1217, doi. 10.1093/neuonc/noac153
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Opportunities and challenges for the development of "core outcome sets" in neuro-oncology.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 7, p. 1048, doi. 10.1093/neuonc/noac062
    By:
    • Millward, Christopher P;
    • Armstrong, Terri S;
    • Barrington, Heather;
    • Brodbelt, Andrew R;
    • Bulbeck, Helen;
    • Byrne, Anthony;
    • Dirven, Linda;
    • Gamble, Carrol;
    • Grundy, Paul L;
    • Islim, Abdurrahman I;
    • Javadpour, Mohsen;
    • Keshwara, Sumirat M;
    • Krishna, Sandhya T;
    • Mallucci, Conor L;
    • Marson, Anthony G;
    • McDermott, Michael W;
    • Meling, Torstein R;
    • Oliver, Kathy;
    • Pizer, Barry;
    • Plaha, Puneet
    Publication type:
    Article
    14

    Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 7, p. 1126, doi. 10.1093/neuonc/noac050
    By:
    • Herrgott, Grayson A;
    • Asmaro, Karam P;
    • Wells, Michael;
    • Sabedot, Thais S;
    • Malta, Tathiane M;
    • Mosella, Maritza S;
    • Nelson, Kevin;
    • Scarpace, Lisa;
    • Barnholtz-Sloan, Jill S;
    • Sloan, Andrew E;
    • Selman, Warren R;
    • deCarvalho, Ana C;
    • Poisson, Laila M;
    • Mukherjee, Abir;
    • Robin, Adam M;
    • Lee, Ian Y;
    • Snyder, James;
    • Walbert, Tobias;
    • Rosenblum, Mark;
    • Mikkelsen, Tom
    Publication type:
    Article
    15
    16
    17
    18

    Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 7, p. 1074, doi. 10.1093/neuonc/noab302
    By:
    • Knudsen, Arnon Møldrup;
    • Halle, Bo;
    • Cédile, Oriane;
    • Burton, Mark;
    • Baun, Christina;
    • Thisgaard, Helge;
    • Anand, Atul;
    • Hubert, Christopher;
    • Thomassen, Mads;
    • Michaelsen, Signe Regner;
    • Olsen, Birgitte Brinkmann;
    • Dahlrot, Rikke Hedegaard;
    • Bjerkvig, Rolf;
    • Lathia, Justin Durla;
    • Kristensen, Bjarne Winther
    Publication type:
    Article
    19

    Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 7, p. 1140, doi. 10.1093/neuonc/noab282
    By:
    • Lim-Fat, Mary Jane;
    • Youssef, Gilbert C;
    • Touat, Mehdi;
    • Iorgulescu, J Bryan;
    • Whorral, Sydney;
    • Allen, Marie;
    • Rahman, Rifaquat;
    • Chukwueke, Ugonma;
    • McFaline-Figueroa, J Ricardo;
    • Nayak, Lakshmi;
    • Lee, Eudocia Q;
    • Batchelor, Tracy T;
    • Arnaout, Omar;
    • Peruzzi, Pier Paolo;
    • Chiocca, E Antonio;
    • Reardon, David A;
    • Meredith, David;
    • Santagata, Sandro;
    • Beroukhim, Rameen;
    • Bi, Wenya Linda
    Publication type:
    Article
    20

    Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 7, p. 1150, doi. 10.1093/neuonc/noab300
    By:
    • Billy, Emmanuel de;
    • Pellegrino, Marsha;
    • Orlando, Domenico;
    • Pericoli, Giulia;
    • Ferretti, Roberta;
    • Businaro, Pietro;
    • Ajmone-Cat, Maria Antonietta;
    • Rossi, Sabrina;
    • Petrilli, Lucia Lisa;
    • Maestro, Nicola;
    • Diomedi-Camassei, Francesca;
    • Pezzullo, Marco;
    • Stefanis, Cristiano De;
    • Bencivenga, Paola;
    • Palma, Alessia;
    • Rota, Rossella;
    • Bufalo, Francesca Del;
    • Massimi, Luca;
    • Weber, Gerrit;
    • Jones, Chris
    Publication type:
    Article
    21
    22
    23

    Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional study.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 7, p. 1166, doi. 10.1093/neuonc/noab284
    By:
    • Lucas, John T;
    • Tinkle, Christopher L;
    • Huang, Jie;
    • Onar-Thomas, Arzu;
    • Srinivasan, Sudharsan;
    • Tumlin, Parker;
    • Becksfort, Jared B;
    • Klimo, Paul;
    • Boop, Frederick A;
    • Robinson, Giles W;
    • Orr, Brent A;
    • Harreld, Julie H;
    • Krasin, Matthew J;
    • Northcott, Paul A;
    • Ellison, David W;
    • Gajjar, Amar;
    • Merchant, Thomas E
    Publication type:
    Article
    24

    Evaluation of dose, volume, and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg Study.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 7, p. 1193, doi. 10.1093/neuonc/noab301
    By:
    • Peters, Sarah;
    • Merta, Julien;
    • Schmidt, Laura;
    • Jazmati, Danny;
    • Kramer, Paul-Heinz;
    • Blase, Cristoph;
    • Tippelt, Stephan;
    • Fleischhack, Gudrun;
    • Stock, Annika;
    • Bison, Brigitte;
    • Rutkowski, Stefan;
    • Pietsch, Torsten;
    • Kortmann, Rolf-Dieter;
    • Timmermann, Beate
    Publication type:
    Article
    25

    Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 7, p. 1178, doi. 10.1093/neuonc/noab293
    By:
    • Leary, Sarah E S;
    • Kilburn, Lindsay;
    • Geyer, J Russell;
    • Kocak, Mehmet;
    • Huang, Jie;
    • Smith, Kyle S;
    • Hadley, Jennifer;
    • Ermoian, Ralph;
    • MacDonald, Tobey J;
    • Goldman, Stewart;
    • Phillips, Peter;
    • Poussaint, Tina Young;
    • Olson, James M;
    • Ellison, David W;
    • Dunkel, Ira J;
    • Fouladi, Maryam;
    • Onar-Thomas, Arzu;
    • Northcott, Paul A
    Publication type:
    Article
    26
    27
    28